| Basic Information | |
|---|---|
| Species | Glycine max |
| Cazyme ID | Glyma09g33330.1 |
| Family | GT47 |
| Protein Properties | Length: 410 Molecular Weight: 47185.7 Isoelectric Point: 7.9018 |
| Chromosome | Chromosome/Scaffold: 09 Start: 39814457 End: 39819050 |
| Description | Exostosin family protein |
| View CDS | |
| External Links |
|---|
| NCBI Taxonomy |
| Plaza |
| CAZyDB |
| Signature Domain Download full data set without filtering | |||
|---|---|---|---|
| Family | Start | End | Evalue |
| GT47 | 85 | 362 | 0 |
| EKKFKVYIYPDGDPNTFYQTPRKLTGKYASEGYFFQNIRDSRFRTENPDEAHLFFIPISCHKMRGKGTSYENMTIIVQNYVESLISKYPYWNRTLGADHF FVTCHDVGVRATEGLEFLVKNSIRAVCSPSYDVGFIPHKDVALPQVLQPFALPAGGNDIENRTTLGFWAGHRNSKIRVILARVWENDTELDISNNRISRA TGHLVYQKRFYRSKFCICPGGSQVNSARIADSIHYGCIPVILSNYYDLPFNDILDWNKFAVVLKESDVYQLKQILKNI | |||
| Full Sequence |
|---|
| Protein Sequence Length: 410 Download |
| MMTGKQGFFS LRGSLLFLAV LTLLSFTYLS LKYSTPTPQV TNLSVEKLND APGTEKEEEG 60 GGEEEEVPDT FHSPRVFKLN YEEMEKKFKV YIYPDGDPNT FYQTPRKLTG KYASEGYFFQ 120 NIRDSRFRTE NPDEAHLFFI PISCHKMRGK GTSYENMTII VQNYVESLIS KYPYWNRTLG 180 ADHFFVTCHD VGVRATEGLE FLVKNSIRAV CSPSYDVGFI PHKDVALPQV LQPFALPAGG 240 NDIENRTTLG FWAGHRNSKI RVILARVWEN DTELDISNNR ISRATGHLVY QKRFYRSKFC 300 ICPGGSQVNS ARIADSIHYG CIPVILSNYY DLPFNDILDW NKFAVVLKES DVYQLKQILK 360 NISDAEFVTL HNNLVKVQKH FQWNSPSIRF DAFHLVMYDL WLRHHTIKY* 420 |
| Functional Domains Download unfiltered results here | ||||||||
|---|---|---|---|---|---|---|---|---|
| Cdd ID | Domain | E-Value | Start | End | Length | Domain Description | ||
| pfam03016 | Exostosin | 2.0e-60 | 84 | 362 | 298 | + Exostosin family. The EXT family is a family of tumour suppressor genes. Mutations of EXT1 on 8q24.1, EXT2 on 11p11-13, and EXT3 on 19p have been associated with the autosomal dominant disorder known as hereditary multiple exostoses (HME). This is the most common known skeletal dysplasia. The chromosomal locations of other EXT genes suggest association with other forms of neoplasia. EXT1 and EXT2 have both been shown to encode a heparan sulphate polymerase with both D-glucuronyl (GlcA) and N-acetyl-D-glucosaminoglycan (GlcNAC) transferase activities. The nature of the defect in heparan sulphate biosynthesis in HME is unclear. | ||
| Gene Ontology | |
|---|---|
| GO Term | Description |
| GO:0016020 | membrane |
| Annotations - NR Download unfiltered results here | |||||||
|---|---|---|---|---|---|---|---|
| Source | Hit ID | E-Value | Query Start | Query End | Hit Start | Hit End | Description |
| GenBank | ACU18220.1 | 0 | 1 | 409 | 1 | 409 | unknown [Glycine max] |
| RefSeq | NP_195517.1 | 0 | 4 | 409 | 15 | 425 | exostosin family protein [Arabidopsis thaliana] |
| RefSeq | XP_002266299.1 | 0 | 10 | 409 | 18 | 416 | PREDICTED: hypothetical protein [Vitis vinifera] |
| RefSeq | XP_002307304.1 | 0 | 10 | 409 | 3 | 406 | predicted protein [Populus trichocarpa] |
| RefSeq | XP_002522880.1 | 0 | 64 | 409 | 61 | 406 | catalytic, putative [Ricinus communis] |
| Metabolic Pathways | |||
|---|---|---|---|
| Pathway Name | Reaction | EC | Protein Name |
| xylogalacturonan biosynthesis | RXN-9589 | EC-2.4.2.41 | xylogalacturonan β-1,3-xylosyltransferase |
